India's manufacturing sector faces significant challenges as Pfizer and Apple encounter production issues. Pfizer suspended the sale of four antibiotics due to manufacturing deviations at a...
The European Commission has approved the world's first vaccine for Respiratory Syncytial Virus (RSV) in adults aged 60 and over. GSK, the maker of the vaccine...
Pfizer's 20-valent pneumococcal conjugate vaccine, APEXXNAR, has been approved by the Singapore Health Sciences Authority for adults aged 18 and above, becoming the first 20-valent pneumococcal...
One dose of the Pfizer or AstraZeneca vaccines reduces the chances of someone infected with coronavirus from spreading it to other household members by up to...
The head of Pfizer said in an interview aired Thursday that people will “likely” need a third dose of his company’s COVID-19 shot within six to...
Pfizer/BioNTech’s coronavirus vaccine offers more protection than earlier thought with effectiveness in preventing symptomatic disease reaching 97 percent, according to real-world evidence published Thursday by the...
The Pfizer COVID-19 vaccine proved 94 per cent effective in a huge real world study published Wednesday that involved 1.2 million people in Israel, confirming the...
The first dose of the Pfizer vaccination is 85 percent effective against coronavirus infection between two and four weeks after inoculation, according to a study published...
North Korean hackers tried to break into the computer systems of pharmaceutical giant Pfizer in a search for information on a coronavirus vaccine and treatment technology,...
Recent Comments